InsidersTradesSigma
Discover the full directors' dealings record of 중앙백신, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 중앙백신 has published 1 insider filings. Market capitalisation: €93.6bn. The latest transaction was reported on 9 March 2026 — Other. Among the most active insiders: 중앙백신. Every trade is openly available.
FY ended December 2025 · cache
1 of 1 declaration